Livongo Diabetes Management
Personalized tools and support to track blood sugar levels and develop healthier lifestyle habits
Company profile
Company profile
Livongo by Teladoc Health is a comprehensive digital chronic condition management platform that serves over 730,000 patients with conditions including diabetes, hypertension, and weight challenges. The company provides a one-of-a-kind approach combining connected health-monitoring devices, certified health coaches, and support from physicians and mental health specialists. Members receive smart devices such as blood glucose meters with unlimited strips, blood pressure monitors, and connected scales that automatically upload health data. The platform offers personalized health plans tailored to individual lifestyles, goals, and health data, with support available in multiple languages including Spanish. Livongo's program is based on clinical standards of care from leading organizations including the American Diabetes Association, American Heart Association, and Centers for Disease Control and Prevention. The service includes unlimited access to dedicated health coaches who monitor diet, exercise, medication, motivation, nutrition, and mental health. With 24/7 monitoring capabilities, the team proactively reaches out when dangerous health levels are detected. The platform has demonstrated significant clinical outcomes, including a 48% reduced incidence of diabetes over three years, 15mmHg average systolic blood pressure reduction, and 46% of patients losing 5% or more of their starting weight. Livongo is available at no cost to eligible members through their employer, health plan, or healthcare provider, and includes a mobile app for tracking progress and accessing personalized insights.
Company description Livongo official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
Company milestones
Serving 730,000+ patients, GLP-1 medication prescribing capability added to condition management programs
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Personalized tools and support to track blood sugar levels and develop healthier lifestyle habits
Get ahead of diabetes with medically certified content, activity tracking and ongoing coaching
Discover lifestyle changes that can reduce blood pressure with daily tracking and support
Find tips and techniques that work for you to improve nutrition, exercise and weight loss
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Patient education and counseling · Sep 1, 2022
A Real-World Comparative Effectiveness Analysis of Thromboprophylactic Use of Enoxaparin Versus Unfractionated Heparin in Abdominal Surgery Patients in a Large U.S. Hospital Database.Hospital pharmacy · Feb 1, 2022
Weight Loss-Associated Decreases in Medical Care Expenditures for Commercially Insured Patients With Chronic Conditions.Journal of occupational and environmental medicine · Oct 1, 2021
A Machine Learning Approach to Passively Informed Prediction of Mental Health Risk in People with Diabetes: Retrospective Case-Control Analysis.Journal of medical Internet research · Aug 27, 2021
Real-World Comparative Effectiveness and Cost Comparison of Thromboprophylactic Use of Enoxaparin versus Unfractionated Heparin in 376,858 Medically Ill Hospitalized US Patients.American journal of cardiovascular drugs : drugs, devices, and other interventions · Jul 1, 2021
Impact of a diabetes remote monitoring program on medication adherence.Journal of managed care & specialty pharmacy · Jun 1, 2021
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Over a three-year period for diabetes prevention program participants
For hypertension management program participants
For weight management program participants
Due to healthier lifestyle changes across programs
Diabetes prevention through lifestyle modification and coaching
48% reduced incidence of diabetes over a three-year period
Blood pressure reduction through monitoring and lifestyle changes
15mmHg average systolic blood pressure reduction
Weight loss through personalized coaching and tracking
46% of patients lost 5% or more of their starting weight
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Livongo's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.